Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups

Peer Review reports

Original Submission
11 Jun 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
4 Oct 2021	Reviewed	Reviewer Report
26 Oct 2021	Reviewed	Reviewer Report
2 Nov 2021	Reviewed	Reviewer Report - Koji Komori
7 Nov 2021	Reviewed	Reviewer Report
28 Nov 2021	Author responded	Author comments - Manuel GOMES DAVID
Resubmission - Version 4
28 Nov 2021	Submitted	Manuscript version 4
1 Dec 2021	Author responded	Author comments - Manuel GOMES DAVID
Resubmission - Version 5
1 Dec 2021	Submitted	Manuscript version 5
2 Dec 2021	Author responded	Author comments - Manuel GOMES DAVID
Resubmission - Version 6
2 Dec 2021	Submitted	Manuscript version 6
4 Dec 2021	Reviewed	Reviewer Report
5 Dec 2021	Reviewed	Reviewer Report
8 Dec 2021	Reviewed	Reviewer Report - Koji Komori
19 Dec 2021	Reviewed	Reviewer Report
Resubmission - Version 7
	Submitted	Manuscript version 7
Publishing
20 Dec 2021	Editorially accepted
7 Jan 2022	Article published	10.1186/s12893-021-01449-z

Back to article page